$247.00▲0.00 (0.00%)Stale · unknown old
Sartorius Stedim Biotech S.A. (SDMHF)
R&D to Revenue
4.47%
Fiscal year · Period ending:

SDMHF R&D to Revenue
Latest reported4.47%period ending
Latest reported4.47%period ending
SDMHF FY R&D/Revenue (6.75% → 4.47%)
Latest values, visible window
High-resolution chart · PNG
What is r&d to revenue?
R&D spending as percentage of revenue.
SDMHF r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 4.4684% | |
| 5.1835% | |
| 4.6658% | |
| 3.7908% | |
| 3.8272% | |
| 4.4213% | |
| 5.4989% | |
| 5.0007% | |
| 4.9221% | |
| 4.5203% | |
| 4.6961% | |
| 5.6418% | |
| 6.1182% | |
| 5.6938% | |
| 5.9878% | |
| 6.4266% | |
| 6.1045% | |
| 6.6707% | |
| 7.0385% | |
| 6.8193% | |
| 6.7512% |
Explore More
SDMHF Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance